Your browser doesn't support javascript.
loading
Covered self-expandable metallic stent placement for tumor bleeding from duodenal invasion in patients with unresectable pancreatic cancer.
Shibuki, Taro; Fukushi, Ko; Inoue, Kanae; Taira, Tomonao; Satake, Tomoyuki; Watanabe, Kazuo; Sasaki, Mitsuhito; Imaoka, Hiroshi; Mitsunaga, Shuichi; Ikeda, Masafumi.
Afiliação
  • Shibuki T; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Fukushi K; Department for the Promotion of Drug and Diagnostic Development, Division of Drug and Diagnostic Development Promotion Translational Research Support Office, National Cancer Center Hospital East Chiba Japan.
  • Inoue K; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Taira T; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Satake T; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Watanabe K; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Sasaki M; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Imaoka H; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Mitsunaga S; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Chiba Japan.
Article em En | MEDLINE | ID: mdl-38601268
ABSTRACT
Patients with unresectable pancreatic cancer often present with duodenal bleeding, a potentially life-threatening complication. In our case series of six unresectable pancreatic cancer patients with tumor bleeding, we explored the efficacy and safety of placement of a covered self-expandable metallic stent in the duodenum as a treatment option; we achieved a hemostasis rate of 67% (4/6), with a rebleeding rate of 50% (2/4). No complications occurred with stent placement, except for food impaction in one patient. Covered self-expandable metallic stent placement is a moderately effective treatment option for tumor bleeding in patients with unresectable pancreatic cancer. Although its hemostatic efficacy is limited, covered self-expandable metallic stent placement is safe and beneficial in some cases, warranting consideration in this disease setting with limited treatment options.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article